Further supporting the national efforts to combat COVID-19, Sunshine Healthcare Lanka Ltd—a fully-owned subsidiary of the diversified conglomerate Sunshine Holdings PLC—recently donated 100,000 hydroxychloroquine (HCQ) sulfate tablets (200mg), manufactured by Zydus Cadila—one of the leading pharmaceutical companies present in Sri Lanka— to the Ministry of Health by the staff of Sunshine Healthcare. The tablets, which are worth Rs. 3.6 million, will significantly help in treating COVID-19 positive patients as per the treatment guidelines recommended by the Epidemiology Unit of Ministry of Health.

Commenting on this donation, Sunshine Pharmaceuticals Chief Operating Officer Shantha Bandara said, “At Sunshine Healthcare, we are fully committed to supporting the government and our communities in the global fight against COVID-19. We believe this is a timely donation considering the immediate spike of COVID-19 cases over the last two weeks, especially where our Sri Lanka Navy personnel who were front lining the COVID-19 operations were affected. We are working closely with our strategic partner Zydus Cadila to assist hospitals around the country by bringing down as many tablets as possible, to treat as many infected patients as possible during this critical time. Sunshine Healthcare pledges to continue to do its part to support the government’s efforts at this time of need.”

A leading Indian Pharmaceutical company, Zydus Cadila is a fully integrated, global healthcare provider. With in-depth domain expertise in the field of healthcare, it has strong capabilities across the spectrum of the pharmaceutical value chain. From formulations to active pharmaceutical ingredients and animal healthcare products to wellness products, Zydus has earned a reputation amongst Indian pharmaceutical companies for providing comprehensive and complete healthcare solutions.

Sunshine Healthcare Lanka (SHL), established in 1967, is the partner of choice for international healthcare companies seeking to grow their business in Sri Lanka, in the areas of pharmaceuticals, medical devices and consumer health products. Sunshine Healthcare is a leading market expansion services provider, with the most extensive specialized healthcare team, with over 300 medical marketing and sales personnel as well as 200 physical distribution personnel. The company offers the local healthcare industry a broad range of customized services from registration to importation, customs clearance, sales, marketing and merchandising, warehousing, physical distribution, invoicing and cash collection. Some of the Sunshine Healthcare partners are Zydus Cadila, Glenmark Pharmaceuticals, Abbott Laboratories, Novo Nordisk, Cadil Pharmaceuticals, 3M Healthcare, Johnson & Johnson Medical Devices, GE Healthcare and Siemens Healthineers.

Photo caption: Shantha Bandara, Chief Operating Officer and Poravi Balasundaram, General Manager – Marketing of Sunshine Pharmaceuticals handing over the HCQ tablets to Pavithra Wanniarachchi, Minister of Health, Nutrition and Indigenous Medicine and Kanchana Jayarathna, Private Secretary to the Minister of Health